Merck to acquire Australian biotech firm Viralytics for $394m to bolster oncolytic immunotherapy treatments

Significant Acquisition in Pharma Industry: US pharmaceutical giant Merck has announced a definitive agreement to acquire Viralytics, an Australian biotech company, for AUD 502 million ... Read More